Author; year; journal
|
Chiou et al. 2003; Medical Care
|
Drummond, Jefferson; 1996; British Medical Journal (BMJ)
|
Evers et al. 2005; International Journal of Technology Assessment in Health Care
|
Philips et al. 2006; Pharmacoeconomics
|
Affiliation of authors
|
Academia and industry
|
Academia
|
Academia
|
Academia
|
Published in a peer-reviewed journal
|
Yes
|
Yes
|
Yes
|
Yes
|
Number of references
|
35
|
48
|
30
|
22
|
Purpose
|
To provide a grading system for assessing the quality of health economic evaluations
|
To improve the transparency of reporting
|
To develop a generally accepted criteria list for assessing the methodology of economic evaluation studies in systematic reviews
|
To identify, review, and consolidate currently available guidelines in order to establish a synthesized and consistent quality assessment framework for decision analytic models
|
Development process
|
Selection of criteria from 19 existing guidelines; Use of a conjoint analysis survey of 120 international experts to estimate weights for each criterion
|
Not specified
|
Selection of items from 15 existing guidelines; Use of a Delphi panel consisting of 23 international experts to generate the final criteria list
|
Selection and formulation of items by reviewing and consolidating 15 existing guidelines for good practice in decision-analytic modeling in HTA
|
Time frame
|
Before, during and after peer review
|
Before, during, and after peer review
|
After peer review
|
Before, during, and after peer review
|
Target audience
|
Producers and consumers of economic evaluations
|
Producers and consumers of economic evaluations
|
Consumers intending to conduct a systematic review of trial-based economic evaluations
|
Producers and consumers of model-based economic evaluations
|
Preferred analytical technique
|
Full economic evaluations: cost-minimization-, cost-effectiveness-, cost-utility-, cost-benefit-analysis
|
Full economic evaluations: cost-minimization-, cost-effectiveness-, cost-utility-, cost-benefit-analysis
|
Full economic evaluations based on clinical trials: cohort studies, case–control studies, randomized controlled clinical trials
|
Full economic evaluations based on decision-analytic models
|
Standard reporting format included
|
16 questions which should be asked when appraising the quality of health economic evaluations
|
Ten sections under the three headings of study design, data collection, and analysis and interpretation of results: study question, selection of alternatives, form of evaluation, effectiveness data, benefit measurement and valuation, costing, modeling, adjustments for timing of costs and benefits, allowance for uncertainty, and presentation of results
|
19 questions which should be asked when appraising the quality of health economic evaluations in systematic reviews
|
15 sections under the three key themes of structure, data, and consistency: statement of decision problem/objective, statement of scope/ perspective, rationale for structure, structural assumptions, strategies/comparators, model type, time horizon, disease states/pathways, cycle length, data identification, pre-model data analysis, data incorporation, assessment of uncertainty, internal consistency, and external consistency
|
Number of questions/criteria
|
16
|
35
|
19
|
61
|
Operationalization of the questions/criteria
|
Yes/No
|
Yes/No/Not clear/Not appropriate
|
Yes/No
|
Yes/No/Unclear/Not applicable
|
Use of a quality score
|
Yes
|
No
|
No
|
No
|
Assessment instruction
|
No
|
Yes
|
Yes:
http://www.beoz.unimaas.nl/chec/
|
Yes
|
Pilot test of the guideline |
Yes: Ofman et al.
[31] |
Not specified |
Yes, but no details given |
Yes |